These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG. Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578 [Abstract] [Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
4. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G. Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802 [Abstract] [Full Text] [Related]
5. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma]. Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A. Klin Oczna; 2006 Jun; 108(1-3):55-9. PubMed ID: 16883942 [Abstract] [Full Text] [Related]
13. The success of primary chemotherapy for group D heritable retinoblastoma. Cohen VM, Kingston J, Hungerford JL. Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556 [Abstract] [Full Text] [Related]
14. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
15. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre. Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH. Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458 [Abstract] [Full Text] [Related]
16. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213 [Abstract] [Full Text] [Related]
17. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma]. Qian J, Xue K, Gao YJ, Yuan YF, Shan HD, Bi YW. Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057 [Abstract] [Full Text] [Related]
18. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Trans Am Ophthalmol Soc; 2004 Apr; 102():35-44; discussion 44-5. PubMed ID: 15747743 [Abstract] [Full Text] [Related]
19. Clinical manifestations and treatment of retinoblastoma in Korea. Chung SE, Sa HS, Koo HH, Yoo KH, Sung KW, Ham DI. Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212 [Abstract] [Full Text] [Related]